GLP-1 drugs create new market for collagen, protein and beauty products in India

New Delhi: Companies are rushing to launch products ranging from foods and beverages to face fillers and collagen skincare supplements to capitalise on the side effects of increasingly popular weight-loss drugs such as glucagon-like peptide-1 (GLP-1) medications Ozempic and Mounjaro.

"This is the biggest new demand driver beauty has had in a decade, and it's coming out of a pharmacy, not a trend cycle," said Radhika Ghai, founder of premium cosmetics e-commerce platform Kindlife.